Checkpoint NOW

Afreen Shariff
  • 5.0 (11)
  • MEDICINE
  • UPDATED BIMONTHLY
Checkpoint NOW

All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.

  1. NOV 12

    Episode 29: Balancing conversations about toxicities

    Join hosts Drs. Afreen Shariff and Pauline Funchain as they discuss with health care communications expert Dr. Timothy Gilligan from Cleveland Clinic about the delicate balance between the fear of toxicities and providing meaningful information for patients and caregivers so they feel empowered and engaged.

    54 min

  2. OCT 7

    Episode 28: Alliance Clinical Trial for Immune Mediated toxicities

    Join hosts Dr. Afreen Shariff and Dr. Pauline Funchain as they discuss with Dr. David Kozono, a radiation oncologist at Dana Farber Cancer Institute and the chair of the ALLIANCE clinical trial to set up a national Biorepository to Study Immunotherapy Side Effects. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=/Public/News-A151804-Oct2020

    21 min

  3. AUG 19

    Episode 27: ASPirE- The International Alliance for Support and Prevention of immune related Events

    Join the Executive Committee of ASPirE- Dr. Afreen Shariff, Dr. Pauline Funchain, Dr. Kerry Reynolds, Dr. Alexa Meara and Dr. Elad Sharon as they discuss the new international Initiative that brings clinicians, educators, researchers and patients together to inform science and clinical innovation in irAEs.

    52 min

  4. AUG 13

    Episode 26: Cancer treatments and the Heart

    Learn about the effect of cancer treatments on the heart. Who needs to see a cardiologist before, during and after cancer treatment- the When and Why with oncologist Dr. Susan Dent and cardio oncologist Dr. Robert Copeland-Halperin.

    45 min

  5. JUL 7

    Episode 25: Adrenal Insufficiency- What patients need to know.

    Join Dr. Afreen Shariff and Dr. Pauline Funchain as they break down Adrenal Insufficiency from cancer treatments in simple terms for patients, caregivers and care teams.

    47 min

  6. 10/23/2023

    Episode 24: Costs of adverse events in Renal Cell Carcinoma

    Learn from the experts about the costs associated with irAEs in patients treated for Renal Cell Carcinoma. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts- medical Oncologists Dr. Daniel Geynisman and Dr. Bradley McGregor, MD for an informative and high yield discussion regarding real and hidden costs of adverse events and how this impacts patients.

    25 min

  7. 05/17/2023

    Episode 23: Emotional impact of side effects on patients and caregivers

    Join host Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Psychologist, Dr. Rebecca Shelby about the emotional impacts like stress, depression, and anxiety associated with side effects from cancer treatments.

    31 min

  8. 04/13/2023

    Episode 22: Germline Variants, Toxicities and ICI

    Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts from Dana Farber Cancer Institute, GU Oncologist Dr. Toni Choueiri and Quantitative Geneticist Dr. Sasha Gusev as they discuss Germline variants associated with immune checkpoint blockade and associated irAEs.

    19 min
See All (30)

Trailer

Ratings & Reviews

5
out of 5
11 Ratings

About

All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.

Information

  • Creator
    Afreen Shariff
  • Years Active
    2020 - 2024
  • Episodes
    30
  • Rating
    Clean
  • Copyright
    © Afreen Shariff
  • Show Website
    Checkpoint NOW

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada